Clinical Trials for Locally Advanced Pancreatic Cancer

Find clinical trials for locally advanced pancreatic cancer. Discover research opportunities and treatment options in your area.

16 Active Trials Found

Showing 16 trials on this page

Page 1 of 1

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

NCT ID: NCT03682289

This clinical trial is investigating a new treatment called Ceralasertib (AZD6738) for patients with various types of solid tumors, including kidney cancer, pancreatic cancer, and endometrial cance...

Recruiting

Phase: PHASE2 Type: interventional Locations: San Francisco, California, United States, Duarte, California, United States +1 more

Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer

NCT ID: NCT04276857

This clinical trial is studying a new treatment approach for patients with locally advanced pancreatic cancer, which is a type of cancer that has spread in the pancreas but is not yet metastatic (m...

Recruiting

Phase: NA Type: interventional Locations: Regina, Saskatchewan, Canada, Saskatoon, Saskatchewan, Canada

A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer

NCT ID: NCT06944587

The NORPACT-3 clinical trial is studying a new approach to treating patients with borderline resectable and locally advanced pancreatic cancer. This trial aims to see if giving patients chemotherap...

Recruiting

Type: observational Locations: Bergen, , Norway, Stavanger, , Norway +3 more

Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer

NCT ID: NCT06378047

This clinical trial is studying a new treatment approach for patients with locally advanced pancreatic cancer that cannot be surgically removed. The trial combines two treatments: Irreversible Elec...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tampa, Florida, United States

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

NCT ID: NCT03257033

This clinical trial is exploring the effectiveness of two different ways to administer chemotherapy for patients with locally advanced pancreatic cancer that cannot be surgically removed. Researche...

Recruiting

Phase: PHASE3 Type: interventional Locations: New York, New York, United States, New Orleans, Louisiana, United States +41 more

Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer

NCT ID: NCT05653453

This clinical trial is studying a new treatment approach for patients with locally advanced pancreatic cancer, which is a type of cancer that has spread but not to distant parts of the body. The tr...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China, Harbin, Heilongjiang, China +3 more

Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)

NCT ID: NCT03652428

This clinical trial is exploring a new treatment approach for locally advanced pancreatic cancer, which is a type of cancer that cannot be easily removed with surgery. The study is testing a combin...

Recruiting

Phase: PHASE1 Type: interventional Locations: Washington, District Of Columbia, United States, Baltimore, Maryland, United States

MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial

NCT ID: NCT05975593

This clinical trial is looking at how radiation therapy affects the environment around tumors in patients with locally advanced cervical cancer and pancreatic cancer. The study will collect various...

Recruiting

Phase: NA Type: interventional Locations: Saint Louis, Missouri, United States

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

NCT ID: NCT06755359

This clinical trial is exploring a new treatment option for patients with locally advanced pancreatic cancer using a device that delivers a special kind of radiation called Alpha DaRT. This device ...

Not yet recruiting

Phase: NA Type: interventional Locations: Poitiers, , France, Bordeaux, , France +6 more

FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma

NCT ID: NCT05466799

This clinical trial is studying a treatment for locally advanced pancreatic cancer, specifically comparing a standard chemotherapy called FOLFIRINOX with a new treatment called OncoSil™ when given ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Adelaide, South Australia, Australia, Adelaide, South Australia, Australia +16 more

mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer

NCT ID: NCT06761027

This clinical trial is investigating a new treatment approach for patients with locally advanced or metastatic pancreatic cancer, which means the cancer has either spread to nearby tissues or other...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fuzhou, Fujian, China, Fuzhou, Fujian, China +2 more

NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus NALIRIFOX as Conversion Therapy of Locally Advanced Pancreatic Cancer

NCT ID: NCT06669078

This clinical trial is studying a new treatment approach for patients with locally advanced pancreatic cancer, which is a challenging stage of the disease. Researchers want to compare two different...

Not yet recruiting

Phase: PHASE2 Type: interventional

NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

NCT ID: NCT06494514

This clinical trial is testing two different treatment options for patients with locally advanced pancreatic cancer, a type of cancer that has spread but is still localized. The study compares a tr...

Recruiting

Phase: NA Type: interventional Locations: Nanjing, Jiangsu, China, Nanjing, Jiangsu, China

Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY

NCT ID: NCT04789980

This clinical trial is investigating the best types of chemotherapy for patients with locally advanced or metastatic pancreatic cancer, which means the cancer has spread beyond the pancreas. Specif...

Recruiting

Type: observational Locations: Seoul, , Korea, Republic Of

Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)

NCT ID: NCT05988372

The SAGE trial is a research study looking at new treatment options for patients with locally advanced pancreatic cancer that cannot be surgically removed. Specifically, it is testing a combination...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

NCT ID: NCT06009029

The SPARK-1 study is a clinical trial designed to explore a new treatment approach for patients with locally advanced pancreatic cancer. This trial will test the combination of a type of radiothera...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions